As the endothelial–mesenchymal transition (EndMT) process can give rise to activated myofibroblasts involved in many fibrotic diseases, we tested the possibility that Rh2 decreased EndMT in dox‐challenged fibrosis herein. This evidence concerns the gene RHAG and fibrosis.